Vaccibody – a novel generation of vaccines

Vaccibody is a vaccine company dedicated to the development of novel vaccines that overcome shortcomings of current vaccine technologies. The Company’s proprietary vaccine platform increases the antibody and T-cell responses leading to remarkably effective vaccines. Vaccibody is focusing on cancer vaccines and is partnering the technology within infection and veterinary use.

 

Vaccibody in the press

Vaccibody is again covered in Norwegian media. This time in Stavanger Aftenblad: Read here, and in "Indikator": Read here. Norwegian only

 
Multiple opportunities to meet Vaccibody

Vaccibody will attend a variety of conferences this spring: